Dr. Mainwaring is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1840 Medical Center Pkwy
Suite 300
Murfreesboro, TN 37129Phone+1 615-848-0488Fax+1 615-904-9061
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 1995 - 1998- University of FloridaResidency, Internal Medicine, 1992 - 1995
Wayne State University School of MedicineClass of 1992
Certifications & Licensure
TN State Medical License 2001 - 2023
FL State Medical License 1994 - 2005
Clinical Trials
- Use of Topotecan in Patients With Refractory Acute Leukemia Start of enrollment: 1998 Aug 01
Publications & Presentations
PubMed
- 6 citationsA Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast CancerDenise A. Yardley, William Liggett, Mark Mainwaring, Aurelio Castrellon, Laura Blakely
Clinical Breast Cancer. 2020-04-01 - 5 citationsRegorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety...Andrew S. Kennedy, Dianna Shipley, Max Shpak, Laura Blakely, Brian Hemphill
Frontiers in Oncology. 2019-07-10 - 11 citationsA Phase II Study with Lead‐In Safety Cohort of 5‐Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients w...Gregg C. Shepard, Edward Arrowsmith, Patrick Murphy, J. H. Barton, James D. Peyton
The Oncologist. 2017-10-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
